EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Timing of immune checkpoint inhibitors infusion and prognosis in recurrent/metastatic nasopharyngeal carcinoma: a single-center, retrospective study

Lin Zhang, Xia Gan, Zhengzheng Yu, Wenji Xie, Xiaowen Sun, Yue Li, Jianing Fang, Yating Liu, Zhongjie Liu, Yaning Tang, Can Zhou, Zhuolong Xie und 9 weitere

Cancer Immunology, Immunotherapy · 2026

DOI: 10.1007/s00262-026-04472-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2026. Verfasst von Lin Zhang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, C…. Hauptthemen laut MEDLINE: Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitors, Nasopharyngeal Neoplasms, Neoplasm Recurrence, Local. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nasopharyngeal CarcinomaImmune Checkpoint InhibitorsNasopharyngeal NeoplasmsNeoplasm Recurrence, LocalHumansRetrospective StudiesFemaleMalePrognosisMiddle AgedAdultAgedNeoplasm Metastasis

Stichwörter der Autor:innen

ChronotherapyCircadian rhythmImmune checkpoint inhibitorsMetastasisNasopharyngeal carcinoma

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, People's Republic of China.
  • Hunan Key Laboratory of Translational Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan Province, Changsha, People's Republic of…
  • Department of Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, People's Republic of China. liyanxian@hnca.org…
  • Department of Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, People's Republic of China. wanghui@hnca.org.c…
  • Department of Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, People's Republic of China. liuhuai@hnca.org.c…

ORCID-Profile: Huai Liu

Zitieren

APA

Zhang, L., Gan, X., Yu, Z., Xie, W., Sun, X., Li, Y., Fang, J., Liu, Y., Liu, Z., Tang, Y., Zhou, C., Xie, Z., Ouyang, S., Zhang, J., Wang, J., Li, H., Liu, F., Chen, P., Li, Y., …, & Liu, H. (2026). Timing of immune checkpoint inhibitors infusion and prognosis in recurrent/metastatic nasopharyngeal carcinoma: a single-center, retrospective study. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-026-04472-2

Vancouver

Zhang L, Gan X, Yu Z, Xie W, Sun X, Li Y, et al. Timing of immune checkpoint inhibitors infusion and prognosis in recurrent/metastatic nasopharyngeal carcinoma: a single-center, retrospective study. Cancer Immunology, Immunotherapy. 2026. doi:10.1007/s00262-026-04472-2

BibTeX
@article{Zhang2026,
  author = {Zhang, Lin and Gan, Xia and Yu, Zhengzheng and Xie, Wenji and Sun, Xiaowen and Li, Yue and Fang, Jianing and Liu, Yating and Liu, Zhongjie and Tang, Yaning and Zhou, Can and Xie, Zhuolong and Ouyang, Shuyu and Zhang, Jing and Wang, Jingyu and Li, Hua and Liu, Feng and Chen, Pan and Li, Yanxian and Wang, Hui and Liu, Huai},
  title = {Timing of immune checkpoint inhibitors infusion and prognosis in recurrent/metastatic nasopharyngeal carcinoma: a single-center, retrospective study},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2026},
  doi = {10.1007/s00262-026-04472-2}
}
Kostenlos starten →